S05216 Summary:

BILL NOS05216A
 
SAME ASSAME AS A03072-A
 
SPONSORSAVINO
 
COSPNSRADDABBO, AVELLA, COMRIE, CROCI, GALLIVAN, GOLDEN, GRIFFO, HANNON, KENNEDY, KLEIN, LATIMER, PANEPINTO, PARKER, PERALTA, PERKINS, PERSAUD, RANZENHOFER, RITCHIE, SANDERS, STAVISKY, VALESKY, VENDITTO
 
MLTSPNSR
 
Amd §207, Pub Health L
 
Creates an education and outreach program for the autoimmune disease known as lupus; provides for an advisory council consisting of representatives of people with lupus and their families and health care providers who specialize in treating lupus.
Go to top    

S05216 Actions:

BILL NOS05216A
 
05/07/2015REFERRED TO HEALTH
05/28/2015REPORTED AND COMMITTED TO FINANCE
01/06/2016REFERRED TO HEALTH
05/04/2016REPORTED AND COMMITTED TO FINANCE
05/16/2016AMEND AND RECOMMIT TO FINANCE
05/16/2016PRINT NUMBER 5216A
06/07/2016COMMITTEE DISCHARGED AND COMMITTED TO RULES
06/07/2016ORDERED TO THIRD READING CAL.1490
06/08/2016PASSED SENATE
06/08/2016DELIVERED TO ASSEMBLY
06/08/2016referred to ways and means
06/15/2016substituted for a3072a
06/15/2016ordered to third reading rules cal.330
06/15/2016passed assembly
06/15/2016returned to senate
11/16/2016DELIVERED TO GOVERNOR
11/28/2016SIGNED CHAP.479
Go to top

S05216 Committee Votes:

Go to top

S05216 Floor Votes:

DATE:06/15/2016Assembly Vote  YEA/NAY: 143/0
Yes
Abbate
Yes
Crespo
Yes
Gottfried
Yes
Lopez
Yes
Palumbo
Yes
Simon
Yes
Abinanti
Yes
Crouch
Yes
Graf
Yes
Lupardo
Yes
Paulin
Yes
Simotas
Yes
Arroyo
Yes
Curran
Yes
Gunther
Yes
Lupinacci
Yes
Peoples-Stokes
Yes
Skartados
Yes
Aubry
Yes
Cusick
Yes
Harris
Yes
Magee
Yes
Perry
Yes
Skoufis
Yes
Barclay
Yes
Cymbrowitz
Yes
Hawley
Yes
Magnarelli
Yes
Pichardo
Yes
Solages
Yes
Barrett
Yes
Davila
Yes
Hevesi
Yes
Malliotakis
Yes
Pretlow
Yes
Stec
Yes
Barron
Yes
DenDekker
Yes
Hikind
Yes
Markey
Yes
Quart
Yes
Steck
Yes
Benedetto
Yes
Dilan
Yes
Hooper
Yes
Mayer
Yes
Ra
Yes
Stirpe
Yes
Bichotte
Yes
Dinowitz
Yes
Hunter
Yes
McDonald
Yes
Raia
Yes
Tedisco
Yes
Blake
ER
DiPietro
Yes
Hyndman
Yes
McDonough
Yes
Ramos
Yes
Tenney
Yes
Blankenbush
Yes
Duprey
Yes
Jaffee
Yes
McKevitt
Yes
Richardson
Yes
Thiele
Yes
Brabenec
Yes
Englebright
Yes
Jean-Pierre
Yes
McLaughlin
Yes
Rivera
Yes
Titone
Yes
Braunstein
Yes
Fahy
Yes
Johns
Yes
Miller
Yes
Robinson
Yes
Titus
ER
Brennan
Yes
Farrell
Yes
Joyner
Yes
Montesano
Yes
Rodriguez
Yes
Walker
Yes
Brindisi
ER
Finch
Yes
Katz
Yes
Morelle
Yes
Rosenthal
Yes
Walter
Yes
Bronson
Yes
Fitzpatrick
Yes
Kavanagh
Yes
Mosley
Yes
Rozic
Yes
Weinstein
Yes
Buchwald
Yes
Friend
Yes
Kearns
Yes
Moya
Yes
Russell
Yes
Weprin
Yes
Butler
Yes
Galef
ER
Kim
Yes
Murray
Yes
Ryan
Yes
Williams
Yes
Cahill
Yes
Gantt
Yes
Kolb
Yes
Nojay
Yes
Saladino
Yes
Woerner
Yes
Cancel
Yes
Garbarino
Yes
Lalor
Yes
Nolan
Yes
Santabarbara
Yes
Wozniak
Yes
Castorina
Yes
Giglio
Yes
Lavine
Yes
Oaks
Yes
Schimel
Yes
Wright
Yes
Ceretto
Yes
Gjonaj
Yes
Lawrence
Yes
O'Donnell
Yes
Schimminger
Yes
Zebrowski
Yes
Colton
Yes
Glick
Yes
Lentol
Yes
Ortiz
Yes
Seawright
Yes
Mr. Speaker
Yes
Cook
Yes
Goldfeder
Yes
Lifton
Yes
Otis
ER
Sepulveda
Yes
Corwin
Yes
Goodell
Yes
Linares
Yes
Palmesano
Yes
Simanowitz

‡ Indicates voting via videoconference
Go to top

S05216 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         5216--A
 
                               2015-2016 Regular Sessions
 
                    IN SENATE
 
                                       May 7, 2015
                                       ___________
 
        Introduced  by  Sens.  SAVINO, ADDABBO, AVELLA, COMRIE, CROCI, GALLIVAN,
          GOLDEN, GRIFFO, HANNON, KENNEDY, KLEIN,  LATIMER,  PANEPINTO,  PARKER,
          PERALTA, PERKINS, RANZENHOFER, RITCHIE, STAVISKY, VALESKY, VENDITTO --
          read  twice  and  ordered printed, and when printed to be committed to
          the Committee on Health -- recommitted to the Committee on  Health  in
          accordance  with Senate Rule 6, sec. 8 -- reported favorably from said
          committee and committed to  the  Committee  on  Finance  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee
 
        AN  ACT  to amend the public health law, in relation to the lupus educa-
          tion and outreach program
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Legislative  intent.  The  legislature  hereby  finds the
     2  following:
     3    (a) Lupus is a serious, complex, debilitating autoimmune disease  that
     4  can  cause  inflammation and tissue damage to virtually any organ system
     5  in the body, including the skin, joints, other connective tissue,  blood
     6  and blood vessels, heart, lungs, kidney, and brain.
     7    (b)  Lupus research estimates that approximately one and a half to two
     8  million Americans live with some form of lupus; lupus affects women nine
     9  times more often than men and eighty percent of newly diagnosed cases of
    10  lupus develop among women of childbearing age.
    11    (c) Lupus disproportionately affects women of color -- it  is  two  to
    12  three  times  more common among African-Americans, Hispanics, Asians and
    13  Native Americans and is generally more prevalent in minority populations
    14  -- a health disparity that remains unexplained. According to the Centers
    15  for Disease Control and Prevention  the  rate  of  lupus  mortality  has
    16  increased  since the late 1970s and is higher among older African-Ameri-
    17  can women.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01779-02-6

        S. 5216--A                          2
 
     1    (d) No new drugs have been approved by the U.S. Food and Drug Adminis-
     2  tration specifically for lupus in nearly forty years and  while  current
     3  treatments  for  the disease can be effective, they can lead to damaging
     4  side effects.
     5    (e)  The  pain and fatigue associated with lupus can threaten people's
     6  ability to live independently, make it difficult to maintain  employment
     7  and  lead normal lives, and one in five people with lupus is disabled by
     8  the disease, and consequently receives support from government programs,
     9  including Medicare, Medicaid, social  security  disability,  and  social
    10  security supplemental income.
    11    (f)  The  estimated  average  annual  cost of medical treatment for an
    12  individual with lupus can range between ten thousand dollars and  thirty
    13  thousand  dollars;  for  people who have the most serious form of lupus,
    14  medical costs can greatly exceed  this  amount,  causing  a  significant
    15  economic, emotional and social burden to the entire family and society.
    16    (g)  More than half of the people with lupus suffer four or more years
    17  and visit three or more  physicians  before  obtaining  a  diagnosis  of
    18  lupus;  early  diagnosis  of and commencement of treatment for lupus can
    19  prevent or reduce serious organ damage, disability, and death.
    20    (h) Despite the magnitude of lupus and its impact on  individuals  and
    21  families,  health professional and public understanding of lupus remains
    22  low; only one of five Americans can provide even basic information about
    23  lupus, and awareness of lupus is lowest among adults  ages  eighteen  to
    24  thirty-four -- the age group most likely to develop symptoms of lupus.
    25    (i)  Lupus  is  a  significant  national  health issue that deserves a
    26  comprehensive and coordinated response by state and federal  governments
    27  with involvement of the health care provider, patient, and public health
    28  communities.
    29    §  2. Subdivision 1 of section 207 of the public health law is amended
    30  by adding a new paragraph (m) to read as follows:
    31    (m) Lupus, a debilitating autoimmune disease that can cause  inflamma-
    32  tion  and  tissue  damage  to  virtually  any  organ system in the body,
    33  including the skin, joints, other connective  tissue,  blood  and  blood
    34  vessels, heart, lung, kidney and brain, and which affects women, partic-
    35  ularly  women  of color, in a disproportionate manner; provided that the
    36  program shall include an advisory council under this section that  shall
    37  include  representatives  of  people  with  lupus and their families and
    38  health care providers who specialize in treating lupus, among others.
    39    § 3. Subdivision 7 of section 207 of the public health law, as amended
    40  by section 16 of part A of chapter 109 of the laws of 2010,  is  amended
    41  to read as follows:
    42    7.  In  addition  to  state funds appropriated for programs under this
    43  section, the commissioner may  accept  grants  from  public  or  private
    44  sources  for  these  programs.  The  commissioner, in administering this
    45  section, shall seek to coordinate the department's programs  with  other
    46  public  and  private  programs,  and  may undertake joint or cooperative
    47  programs with other public or private entities, including making  grants
    48  (within  amounts  appropriated  therefor  and consistent with applicable
    49  law) to public or not-for-profit entities.
    50    § 4. This act shall take effect immediately.
Go to top